CA2577437A1 - Creatine-fatty acids - Google Patents

Creatine-fatty acids Download PDF

Info

Publication number
CA2577437A1
CA2577437A1 CA002577437A CA2577437A CA2577437A1 CA 2577437 A1 CA2577437 A1 CA 2577437A1 CA 002577437 A CA002577437 A CA 002577437A CA 2577437 A CA2577437 A CA 2577437A CA 2577437 A1 CA2577437 A1 CA 2577437A1
Authority
CA
Canada
Prior art keywords
creatine
fatty acid
compounds
produced
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002577437A
Other languages
French (fr)
Other versions
CA2577437C (en
Inventor
Shan Chaudhuri
Joseph Macdougall
Jason Peters
James Ramsbottom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations Holding Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002577437A priority Critical patent/CA2577437C/en
Publication of CA2577437A1 publication Critical patent/CA2577437A1/en
Application granted granted Critical
Publication of CA2577437C publication Critical patent/CA2577437C/en
Priority to CA 2622478 priority patent/CA2622478A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention describes compounds produced from a creatine molecule and a fatty acid molecule. The compounds being in the form of creatine-fatty compounds bound by an amide linkage, or mixtures thereof produced by reacting creatine or derivatives thereof with an appropriate fatty acid in the presence of dichloromethane and a pyridine catalyst, previously reacted with a thionyl halide. The administration of such molecules provides supplemental creatine with enhanced bioavailability and the additional benefits conferred by the specific fatty acid.
CA002577437A 2007-02-20 2007-02-20 Creatine-fatty acids Expired - Fee Related CA2577437C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002577437A CA2577437C (en) 2007-02-20 2007-02-20 Creatine-fatty acids
CA 2622478 CA2622478A1 (en) 2007-02-20 2008-02-20 Creatine-fatty acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002577437A CA2577437C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Publications (2)

Publication Number Publication Date
CA2577437A1 true CA2577437A1 (en) 2007-05-21
CA2577437C CA2577437C (en) 2008-02-12

Family

ID=38066769

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002577437A Expired - Fee Related CA2577437C (en) 2007-02-20 2007-02-20 Creatine-fatty acids

Country Status (1)

Country Link
CA (1) CA2577437C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009076741A1 (en) * 2007-12-18 2009-06-25 Multi Formulations Ltd. Creatinol-fatty acid esters

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009076741A1 (en) * 2007-12-18 2009-06-25 Multi Formulations Ltd. Creatinol-fatty acid esters

Also Published As

Publication number Publication date
CA2577437C (en) 2008-02-12

Similar Documents

Publication Publication Date Title
EP2889624A3 (en) Reversible covalent linkage of functional molecules
WO2006124737A3 (en) Molecular constructs suitable for targeted conjugates
CA2577439A1 (en) Creatine-fatty acids
EP2578600A3 (en) RSV-specific binding molecules and means for producing them
WO2009067686A8 (en) Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof
AU2006236578A1 (en) The use of alkenyl succinic anhydride compounds derived from symmetrical olefins in internal sizing for paper production
TNSN07277A1 (en) Pharmaceutical compounds
WO2006002895A3 (en) Conjugates of antibody and duoarmycin derivatives as antitumor agents
FR2900157B1 (en) PROCESS FOR THE DESULFURATION OF OLEFINIC ESSENCES COMPRISING AT LEAST TWO DISTINCT HYDRODESULFURATION STAGES
FR2906530B1 (en) PROCESS FOR THE SYNTHESIS OF ESTOLID ESTERS
ITTO20050593A1 (en) EXHIBITOR BASE, EXAMPLE EXHIBITOR FOR THE EXPOSURE OF FOOD PRODUCTS
EP2821385A3 (en) Method for the preparation of therapeutically valuable triphenylbutene derivatives
WO2007098124A3 (en) Processes for the convergent synthesis of calicheamicin derivatives
TW200613270A (en) Ionic liquids having fluoroalkyltrifluoroborate anions
ATE452625T1 (en) SUPERLOADED LIPOSOMES FOR DRUG DELIVERY
WO2009105691A3 (en) Uses of pentamidine and related compounds
WO2006006196A3 (en) Synthesis of organometallic molecules that can be used as markers of organic substances
CA2577437A1 (en) Creatine-fatty acids
WO2007002128A3 (en) Compositions comprising and processes for producing inorganic salts of hop acids
FR2933871B1 (en) FORMULATION FOR IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE
WO2008102888A1 (en) Novel pseudoglycolipid and use thereof
WO2007039914A3 (en) Novel polymorphs of telithromycin
MX2008000011A (en) Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes.
CA2611532A1 (en) Creatinol-fatty acid esters
WO2006084941A3 (en) Process for the preparation of irinotecan hydrochloride

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220221

MKLA Lapsed

Effective date: 20220221